TradingView
Kareim
14 Feb 2018 pukul 22.32

New Support Being Created 

Deskripsi

Despite failure at drug trials, stock still ranked "strong buy" by TipRank's 60th best rated analyst and others. May be a an opportunity to buy Call LEAP
Lebih lanjut